ICYMI: Experimental Treatment for Duchenne Muscular Dystrophy Shows Potential in Early Trial
931527 / Pixabay

ICYMI: Experimental Treatment for Duchenne Muscular Dystrophy Shows Potential in Early Trial

According to a story from globenewswire.com, the biotechnology company Wave Life Sciences Ltd. recently announced that the tolerability and safety data from its Phase 1 clinical trial of its investigational therapy…

Continue Reading ICYMI: Experimental Treatment for Duchenne Muscular Dystrophy Shows Potential in Early Trial
Experimental Treatment for Biliary Atresia Gets Orphan Drug Designation in the EU
Capri23auto / Pixabay

Experimental Treatment for Biliary Atresia Gets Orphan Drug Designation in the EU

According to a story from Market Screener, the drug developer Albireo Pharma, Inc., recently announced that its investigational product candidate A4250 has earned Orphan Drug designation from the European Commission.…

Continue Reading Experimental Treatment for Biliary Atresia Gets Orphan Drug Designation in the EU
Device Allows Monitoring of Lung Function at Home For Duchenne Muscular Dystrophy Patients
Myriams-Fotos / Pixabay

Device Allows Monitoring of Lung Function at Home For Duchenne Muscular Dystrophy Patients

According to a story from EurekAlert!, monitoring lung function is an important role of managing Duchenne muscular dystrophy and other diseases that can cause wasting of the respiratory muscles. Many…

Continue Reading Device Allows Monitoring of Lung Function at Home For Duchenne Muscular Dystrophy Patients
New Open Data Portal Will Improve Neurofibromatosis Research
Free-Photos / Pixabay

New Open Data Portal Will Improve Neurofibromatosis Research

According to a story from EurekAlert!, a collaboration of Sage Bionetworks, The Children's Tumor Foundation (CTF), and the Neurofibromatosis Therapeutic Acceleration Program (NTAP) have announced the initiation of the very…

Continue Reading New Open Data Portal Will Improve Neurofibromatosis Research
Possible Treatment for Spinal Muscular Atrophy Gains PRIME Designation From the EMA
Belova59 / Pixabay

Possible Treatment for Spinal Muscular Atrophy Gains PRIME Designation From the EMA

According to a story from pm360online.com, the pharmaceutical company Roche recently announced that its investigational therapy risdiplam has awarded PRIME designation from the European Medicines Agency (EMA). The drug has…

Continue Reading Possible Treatment for Spinal Muscular Atrophy Gains PRIME Designation From the EMA
Potential Treatment for Lupus is Granted Fast Track Designation From the FDA
frolicsomepl / Pixabay

Potential Treatment for Lupus is Granted Fast Track Designation From the FDA

According to a story from BioSpace, Incyte Corporation and Eli Lilly and Company recently announced that the US Food and Drug Administration (FDA) has given the drug baricitinib Fast Track…

Continue Reading Potential Treatment for Lupus is Granted Fast Track Designation From the FDA
Can an Intellectually Active Lifestyle Provide Benefits Against Huntington’s Disease? This Study Says Yes
omaralnahi / Pixabay

Can an Intellectually Active Lifestyle Provide Benefits Against Huntington’s Disease? This Study Says Yes

According to a story from news-medical.net, a team of researchers has found that patients who are more intellectually active can slow the neurodegeneration that appears in Huntington's disease. Such as…

Continue Reading Can an Intellectually Active Lifestyle Provide Benefits Against Huntington’s Disease? This Study Says Yes
After Being Ignored by Doctors, Former NFL Cheerleader Accurately Diagnoses Own Pectus Excavatum
Source: Pixabay.com

After Being Ignored by Doctors, Former NFL Cheerleader Accurately Diagnoses Own Pectus Excavatum

According to a story from NTD, a former NFL cheerleader successfully diagnosed her own rare disease, pectus excavatum, after her symptoms were dismissed by her doctors as nothing more than…

Continue Reading After Being Ignored by Doctors, Former NFL Cheerleader Accurately Diagnoses Own Pectus Excavatum
Sexism and Misdiagnosis Led to Years of Suffering for This Chronic Fatigue Syndrome Patient
Counselling / Pixabay

Sexism and Misdiagnosis Led to Years of Suffering for This Chronic Fatigue Syndrome Patient

According to a story from Cosmopolitan, a young woman who we will call Courtney (real name changed for privacy) was diagnosed with chronic fatigue syndrome. However, this diagnosis only occurred…

Continue Reading Sexism and Misdiagnosis Led to Years of Suffering for This Chronic Fatigue Syndrome Patient
Markelle Fultz of the Philadelphia Sixers was Diagnosed With Thoracic Outlet Syndrome. What Does This Mean?
Pexels / Pixabay

Markelle Fultz of the Philadelphia Sixers was Diagnosed With Thoracic Outlet Syndrome. What Does This Mean?

According to a story from philly.com, Markelle Fultz, who plays as a guard for the Philadelphia 76ers, was recently diagnosed with thoracic outlet syndrome. It has not been good news…

Continue Reading Markelle Fultz of the Philadelphia Sixers was Diagnosed With Thoracic Outlet Syndrome. What Does This Mean?
New Measure Developed to Assess the Severity of Charcot-Marie-Tooth Disease in Babies
1041483 / Pixabay

New Measure Developed to Assess the Severity of Charcot-Marie-Tooth Disease in Babies

According to a story from Charcot-Marie-Tooth News, a group of scientists have developed a new scale that can be used to predict disease severity in infants that are diagnosed with…

Continue Reading New Measure Developed to Assess the Severity of Charcot-Marie-Tooth Disease in Babies
Phase 1 Gene Transfer Trial for Recessive Dystrophic Epidermolysis Bullosa is Recruiting Patients
PixLoger / Pixabay

Phase 1 Gene Transfer Trial for Recessive Dystrophic Epidermolysis Bullosa is Recruiting Patients

According to a story from Debra of America, a new Phase 1 clinical trial being operated by Stanford University is currently recruiting participants. This trial will be a test of…

Continue Reading Phase 1 Gene Transfer Trial for Recessive Dystrophic Epidermolysis Bullosa is Recruiting Patients
Scientists May Have Found a New Way to Predict The Severity of Type 2A Charcot-Marie-Tooth Disease
DarkoStojanovic / Pixabay

Scientists May Have Found a New Way to Predict The Severity of Type 2A Charcot-Marie-Tooth Disease

According to a story from Charcot-Marie-Tooth news, researchers have found that models of mutations affecting the mitofusin 2 protein (MFN2), which is the protein that is affected Charcot-Marie-Tooth disease type…

Continue Reading Scientists May Have Found a New Way to Predict The Severity of Type 2A Charcot-Marie-Tooth Disease